From a prognostic perspective, miR-338-3p downregulation correlates with shorter OS and RFS [48], while miR-3191-5p suppresses tumor progression via the ADGRB1/p53 axis and is strongly linked to patient survival [47]. The gene discussed is TP53; the disease is neoplasm.